Posts tagged as

Diabetes

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes The UFDI team is dedicated to improving the lives of people affected by type 1 diabetes (T1D). Over the last 25 years, UFDI investigators have played a major role in nearly every clinical trial that has demonstrated a novel…

Dr. Stabler awarded R01 grant from the NIH NIDDK

Congratulations to Cherie Stabler, Ph.D., professor in the J. Crayton Pruitt Family Department of Biomedical Engineering, for receiving a $1.7 million RO1 grant from the NIH National Institute of Diabetes and Digestive and Kidney Diseases for her project, “Engineering Immunomodulatory Nanoscale Coatings for Protecting Islet Transplants.”…

2020 Bluevember Events

In honor of National Diabetes Awareness Month, the University of Florida Diabetes Institute (UFDI) will host a series of events designed to engage our campus community, the Gainesville population, and key diabetes stakeholders for our state of Florida. World Diabetes Day Seminar…

2020-2021 Seminars

Rohit N. Kulkarni MD, PhD, Professor of Medicine, Harvard Medical School; Margaret A. Congleton Chair and Senior Investigator, Joslin Diabetes Center Seminar Title: “The role of m6A mRNA methylation in regulating beta cell biology”…

Lecture: “Treatment of T2D Non-insulin w/Agents ”

Join the Division of Endocrinology, Diabetes, & Metabolism Conferences for a zoom webinar on July 29, 2020 from 3:00 p.m. to 4:00 p.m. *Register to receive Meeting ID & Password via E-mail: https://ufl.zoom.us/meeting/register/tJIvdO2vrDMqH9ZCOb67c0vaASB53LlX1p-I Presented by: Kenneth Cusi MD, FACP, FACE, UFDI Adult Medical Director, Chief, Clinical Professor & VA Faculty in…

Diabetes Disparities in the Time of COVID-19

Ashby Walker, Ph.D., UF Diabetes Institute director of health equity initiatives, is the keynote speaker on an ECHO Project webinar about “Diabetes Disparities in the Time of COVID-19”. This webinar will address the urgent needs of patients with type 1 and type 2 diabetes who require complex…